Bruce Neil Dawson Sells 3,129 Shares of IBEX (NASDAQ:IBEX) Stock

IBEX Limited (NASDAQ:IBEXGet Free Report) insider Bruce Neil Dawson sold 3,129 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $32.80, for a total value of $102,631.20. Following the sale, the insider directly owned 77,155 shares of the company’s stock, valued at $2,530,684. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Bruce Neil Dawson also recently made the following trade(s):

  • On Tuesday, May 12th, Bruce Neil Dawson sold 15,260 shares of IBEX stock. The shares were sold at an average price of $31.12, for a total value of $474,891.20.

IBEX Stock Down 1.9%

IBEX stock traded down $0.58 during midday trading on Wednesday, reaching $30.44. 131,450 shares of the company’s stock traded hands, compared to its average volume of 133,603. The company has a 50-day simple moving average of $28.62 and a two-hundred day simple moving average of $33.29. IBEX Limited has a 1-year low of $25.94 and a 1-year high of $42.99. The company has a market cap of $407.59 million, a price-to-earnings ratio of 9.51 and a beta of 0.66.

IBEX (NASDAQ:IBEXGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.05. IBEX had a return on equity of 31.50% and a net margin of 7.53%.The firm had revenue of $164.41 million during the quarter, compared to analysts’ expectations of $157.00 million.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on IBEX. Wall Street Zen raised IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 21st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of IBEX in a report on Monday, May 4th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.

View Our Latest Research Report on IBEX

Institutional Investors Weigh In On IBEX

Hedge funds and other institutional investors have recently made changes to their positions in the company. Advisory Services Network LLC acquired a new stake in shares of IBEX in the 3rd quarter valued at $46,000. Penserra Capital Management LLC acquired a new stake in shares of IBEX in the 3rd quarter valued at $52,000. Amundi acquired a new stake in shares of IBEX in the 1st quarter valued at $74,000. Empowered Funds LLC acquired a new stake in shares of IBEX in the 4th quarter valued at $84,000. Finally, Clearstead Advisors LLC increased its stake in shares of IBEX by 159.1% in the 4th quarter. Clearstead Advisors LLC now owns 2,635 shares of the company’s stock valued at $101,000 after buying an additional 1,618 shares during the period. 81.24% of the stock is owned by institutional investors and hedge funds.

About IBEX

(Get Free Report)

IBEX Holdings, Inc is a global business process outsourcing (BPO) company that specializes in customer experience solutions for a range of industries, including telecommunications, cable, technology, financial services and e-commerce. The company’s core offerings encompass multichannel customer support delivered via voice, email, chat, social media and digital self-service platforms. In addition to front-line contact center services, IBEX provides back-office processing, order management, technical troubleshooting and analytics-driven insights to help clients optimize operational efficiency and customer satisfaction.

Beyond traditional contact center operations, IBEX has built a proprietary technology stack designed to integrate real-time data analytics, workforce management and quality assurance.

See Also

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.